Oladapo Yeku

Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo

Sarwish Rafiq, Oladapo Yeku, Hollie J. Jackson et al. · Nature Biotechnology · 2018 · 823 citations

Medicine, Immunology, Oncology +16

Armored CAR T cells enhance antitumor efficacy and overcome the tumor microenvironment

Oladapo Yeku, Terence J. Purdon, Mythili Koneru et al. · Scientific Reports · 2017 · 403 citations · Full text

Medicine, Immunology, Oncology +17

A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA–MONO/GOG-3020/ENGOT-ov45)

Bradley J. Monk, Christine Parkinson, Myong Cheol Lim et al. · Journal of Clinical Oncology · 2022 · 384 citations · Full text

Medicine, Oncology, Pharmacology +16

Engineered Tumor-Targeted T Cells Mediate Enhanced Anti-Tumor Efficacy Both Directly and through Activation of the Endogenous Immune System

Mauro P. Avanzi, Oladapo Yeku, Xinghuo Li et al. · Cell Reports · 2018 · 331 citations · Full text

Medicine, Immunology, Oncology +17

Losartan treatment enhances chemotherapy efficacy and reduces ascites in ovarian cancer models by normalizing the tumor stroma

Yanxia Zhao, Jinghong Cao, Alexander Melamed et al. · Proceedings of the National Academy of Sciences · 2019 · 259 citations · Full text

Medicine, Oncology, Pharmacology +17